# Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population

> **NCT04395326** · — · UNKNOWN · sponsor: **St. Justine's Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Adverse Drug Event

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04395326
- **Lead sponsor:** St. Justine's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04395326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04395326, "Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04395326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*